Pharmacare Premium, a pharmaceutical manufacturing company in Malta equipped with leading technology machinery, appreciates the abundance of different points of view and cultures in our workforce. As the diversity of…
16 March 2022 Malta’s Pharmacare Premium launches new generic cancer drug Malta-based pharmaceutical firm Pharmacare Premium Ltd is launching generic Sorafenib, a product used for the treatment of kidney and…
Maltese pharmaceutical manufacturing firm Pharmacare Premium Ltd has signed an agreement with Swedish biotechnology company Xspray Pharma AB for the latter to install new production lines at Pharmacare’s existing facility…
MALTA-BASED GENERICS DEVELOPER AND MANUFACTURER PHARMACARE Premium believes it is leading the way on developing a generic pazopanib rival to Novartis’ Votrient cancer treatment for the European market. Malta- Pharmacare…
The Ringing of the Bell ceremony welcoming Pharmacare Finance plc to the Malta Stock Exchange (MSE) Prospects MTF was held at the Exchange on the 12 December 2018. MSE CEO…